189 related articles for article (PubMed ID: 21472718)
21. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.
Thompson JF; Soong SJ; Balch CM; Gershenwald JE; Ding S; Coit DG; Flaherty KT; Gimotty PA; Johnson T; Johnson MM; Leong SP; Ross MI; Byrd DR; Cascinelli N; Cochran AJ; Eggermont AM; McMasters KM; Mihm MC; Morton DL; Sondak VK
J Clin Oncol; 2011 Jun; 29(16):2199-205. PubMed ID: 21519009
[TBL] [Abstract][Full Text] [Related]
22. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
[TBL] [Abstract][Full Text] [Related]
23. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
26. Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
Frinton E; Tong D; Tan J; Read G; Kumar V; Kennedy S; Lim C; Board RE
J Neurooncol; 2017 Dec; 135(3):507-512. PubMed ID: 28819707
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors for survival in melanoma patients with brain metastases.
Davies MA; Liu P; McIntyre S; Kim KB; Papadopoulos N; Hwu WJ; Hwu P; Bedikian A
Cancer; 2011 Apr; 117(8):1687-96. PubMed ID: 20960525
[TBL] [Abstract][Full Text] [Related]
28. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
29. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases.
Nagarajan P; Curry JL; Ning J; Piao J; Torres-Cabala CA; Aung PP; Ivan D; Ross MI; Levenback CF; Frumovitz M; Gershenwald JE; Davies MA; Malpica A; Prieto VG; Tetzlaff MT
Clin Cancer Res; 2017 Apr; 23(8):2093-2104. PubMed ID: 27864417
[No Abstract] [Full Text] [Related]
30. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
31. Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression.
Massi D; Franchi A; Borgognoni L; Reali UM; Santucci M
Cancer; 1999 Mar; 85(5):1067-76. PubMed ID: 10091790
[TBL] [Abstract][Full Text] [Related]
32. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
Lagerwaard FJ; Levendag PC; Nowak PJ; Eijkenboom WM; Hanssens PE; Schmitz PI
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):795-803. PubMed ID: 10098435
[TBL] [Abstract][Full Text] [Related]
33. Clinical correlates and prognostic value of different metastatic sites in patients with malignant melanoma of the skin: a SEER database analysis.
Abdel-Rahman O
J Dermatolog Treat; 2018 Mar; 29(2):176-181. PubMed ID: 28745581
[TBL] [Abstract][Full Text] [Related]
34. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors.
Koc M; McGregor J; Grecula J; Bauer CJ; Gupta N; Gahbauer RA
J Neurooncol; 2005 Feb; 71(3):307-13. PubMed ID: 15735922
[TBL] [Abstract][Full Text] [Related]
35. Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.
Milsch L; Gesierich A; Kreft S; Livingstone E; Zimmer L; Goebeler M; Schadendorf D; Schilling B
Eur J Cancer; 2018 Aug; 99():58-65. PubMed ID: 29906735
[TBL] [Abstract][Full Text] [Related]
36. Increased incidence of brain metastases in cutaneous head and neck melanoma.
Daryanani D; Plukker JT; de Jong MA; Haaxma-Reiche H; Nap R; Kuiper H; Hoekstra HJ
Melanoma Res; 2005 Apr; 15(2):119-24. PubMed ID: 15846145
[TBL] [Abstract][Full Text] [Related]
37. Determinants of survival in patients with brain metastases from cutaneous melanoma.
Staudt M; Lasithiotakis K; Leiter U; Meier F; Eigentler T; Bamberg M; Tatagiba M; Brossart P; Garbe C
Br J Cancer; 2010 Apr; 102(8):1213-8. PubMed ID: 20372154
[TBL] [Abstract][Full Text] [Related]
38. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
39. Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.
In 't Hout FE; Haydu LE; Murali R; Bonenkamp JJ; Thompson JF; Scolyer RA
Ann Surg; 2012 Jun; 255(6):1165-70. PubMed ID: 22566014
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]